ArticleFrontiers in immunology2022

Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study.

Dahai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.